{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:59:30Z","timestamp":1774130370096,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pcd.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T18:50:37Z","timestamp":1726426237000},"page":"565-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of finerenone in the management of CKD in T2D \u2013Practical considerations for primary care"],"prefix":"10.1016","volume":"18","author":[{"given":"Naresh","family":"Kanumilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4968-2367","authenticated-orcid":false,"given":"Martin","family":"Miszon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pcd.2024.09.001_bib1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.pcd.2024.09.001_bib4","article-title":"Chronic kidney disease: its relationship with obesity","volume":"14","author":"Prasad","year":"2022","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.pcd.2024.09.001_bib5","first-page":"2032","article-title":"Challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Diab. Kid. Dis."},{"key":"10.1016\/j.pcd.2024.09.001_bib6","unstructured":"International Diabetes Federation, IDF Diabetes Atlas, 9th edn. 2019: Brussels, Belgium."},{"issue":"4 Suppl 1","key":"10.1016\/j.pcd.2024.09.001_bib7","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US renal data system 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"8","key":"10.1016\/j.pcd.2024.09.001_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.11622\/smedj.2020127","article-title":"Diabetic kidney disease in primary care","volume":"61","author":"Fong","year":"2020","journal-title":"Singap. Med J."},{"issue":"3 Suppl 2","key":"10.1016\/j.pcd.2024.09.001_bib9","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1053\/j.ajkd.2010.11.009","article-title":"Comparison of the CKD epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the kidney early evaluation program (KEEP)","volume":"57","author":"McFarlane","year":"2011","journal-title":"Am. J. Kidney Dis."},{"issue":"11","key":"10.1016\/j.pcd.2024.09.001_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","article-title":"Chronic kidney disease and cardiovascular disease: is there any relationship?","volume":"15","author":"Vallianou","year":"2019","journal-title":"Curr. Cardiol. Rev."},{"issue":"9","key":"10.1016\/j.pcd.2024.09.001_bib12","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/dc21-0723","article-title":"Chronic kidney disease testing among at-risk adults in the U.S. remains low: real-world evidence from a national laboratory database","volume":"44","author":"Alfego","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pcd.2024.09.001_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41581-021-00527-y","article-title":"Educating primary healthcare providers about kidney disease","volume":"18","author":"Bello","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.51866\/rv1186","article-title":"A practical approach to chronic kidney disease in primary care","volume":"17","author":"Cheo","year":"2022","journal-title":"Malays. Fam. Physician"},{"key":"10.1016\/j.pcd.2024.09.001_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/POR.S97310","article-title":"Chronic kidney disease: identification and management in primary care","volume":"7","author":"Fraser","year":"2016","journal-title":"Pragmatic Obs. Res."},{"issue":"3, Supplement 2","key":"10.1016\/j.pcd.2024.09.001_bib16","first-page":"S10","article-title":"The expanding role of primary care providers in care of individuals with kidney disease","volume":"114","author":"Martin","year":"2022","journal-title":"J. Natl. Med. Assoc."},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib17","first-page":"17","article-title":"Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions","volume":"3","author":"Baer","year":"2010","journal-title":"NDT Plus"},{"issue":"11","key":"10.1016\/j.pcd.2024.09.001_bib18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.amjmed.2011.04.026","article-title":"Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review","volume":"124","author":"Smart","year":"2011","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.pcd.2024.09.001_bib19","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","article-title":"The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"99","author":"Shlipak","year":"2021","journal-title":"Kidney Int"},{"issue":"15","key":"10.1016\/j.pcd.2024.09.001_bib21","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.pcd.2024.09.001_bib22","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s12325-023-02482-5","article-title":"Patient management and clinical outcomes associated with a recorded diagnosis of stage 3 chronic kidney disease: the REVEAL-CKD study","volume":"40","author":"Tangri","year":"2023","journal-title":"Adv. Ther."},{"issue":"12","key":"10.1016\/j.pcd.2024.09.001_bib23","first-page":"776","article-title":"Chronic kidney disease: detection and evaluation","volume":"96","author":"Gaitonde","year":"2017","journal-title":"Am. Fam. Physician"},{"issue":"13","key":"10.1016\/j.pcd.2024.09.001_bib24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.pcd.2024.09.001_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2015.162","article-title":"The glycocalyx\u2014linking albuminuria with renal and cardiovascular disease","volume":"11","author":"Rabelink","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12882-016-0303-x","article-title":"Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults","volume":"17","author":"Seliger","year":"2016","journal-title":"BMC Nephrol."},{"issue":"6","key":"10.1016\/j.pcd.2024.09.001_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ckj\/sfx057","article-title":"Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy","volume":"10","author":"Brown","year":"2017","journal-title":"Clin. Kidney J."},{"issue":"3","key":"10.1016\/j.pcd.2024.09.001_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.mnh.0000444813.72626.88","article-title":"Estimating and measuring glomerular filtration rate: methods of measurement and markers for estimation","volume":"23","author":"Lamb","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"5","key":"10.1016\/j.pcd.2024.09.001_bib29","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.21037\/jtd.2016.03.62","article-title":"Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients","volume":"8","author":"Thongprayoon","year":"2016","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.pcd.2024.09.001_bib30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am. J. Kidney Dis."},{"issue":"18","key":"10.1016\/j.pcd.2024.09.001_bib31","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate","volume":"307","author":"Matsushita","year":"2012","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.pcd.2024.09.001_bib32","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2337\/dc12-0259","article-title":"Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes","volume":"35","author":"Targher","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12882-017-0474-0","article-title":"Effect of large weight reductions on measured and estimated kidney function","volume":"18","author":"von Scholten","year":"2017","journal-title":"BMC Nephrol."},{"issue":"12","key":"10.1016\/j.pcd.2024.09.001_bib34","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1007\/s00125-011-2307-1","article-title":"Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?","volume":"54","author":"Iliadis","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/jcm8010089","article-title":"Differences in kidney function estimates based on creatinine and\/or Cystatin C in non-traumatic amputation patients and their impact on drug prescribing","volume":"8","author":"Aakj\u00e6r","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pcd.2024.09.001_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/546039","article-title":"Understanding the mechanisms of proteinuria: therapeutic implications","volume":"2012","author":"Toblli","year":"2012","journal-title":"Int. J. Nephrol."},{"issue":"8","key":"10.1016\/j.pcd.2024.09.001_bib37","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1292\/jvms.14-0427","article-title":"Urinary albumin and transferrin as early diagnostic markers of chronic kidney disease","volume":"77","author":"Maeda","year":"2015","journal-title":"J. Vet. Med. Sci."},{"issue":"7","key":"10.1016\/j.pcd.2024.09.001_bib38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2010091001","article-title":"Changes in albuminuria predict mortality and morbidity in patients with vascular disease","volume":"22","author":"Schmieder","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.pcd.2024.09.001_bib39","doi-asserted-by":"crossref","first-page":"8642628","DOI":"10.1155\/2019\/8642628","article-title":"The effectiveness of dipstick for the detection of urinary tract infection","volume":"2019","author":"Dadzie","year":"2019","journal-title":"Can. J. Infect. Dis. Med Microbiol"},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3343\/alm.2017.37.1.28","article-title":"Comparison of urine albumin-to-creatinine ratio (ACR) between ACR strip test and quantitative test in prediabetes and diabetes","volume":"37","author":"Nah","year":"2017","journal-title":"Ann. Lab Med"},{"issue":"2","key":"10.1016\/j.pcd.2024.09.001_bib41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/19322968211054520","article-title":"Impact of Albumin-to-Creatinine Ratio Point-of-Care Testing on the Diagnosis and Management of Diabetic Kidney Disease","volume":"17","author":"Schultes","year":"2023","journal-title":"J. Diabetes Sci. Technol."},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib42","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1038\/s41598-020-63967-9","article-title":"Addition of metabolic syndrome to albuminuria provides a new risk stratification model for diabetic kidney disease progression in elderly patients","volume":"10","author":"Shih","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pcd.2024.09.001_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1681\/ASN.2008030292","article-title":"First morning voids are more reliable than spot urine samples to assess microalbuminuria","volume":"20","author":"Witte","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2215\/CJN.12681211","article-title":"The primary care perspective on routine urine dipstick screening to identify patients with albuminuria","volume":"8","author":"Samal","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.pcd.2024.09.001_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ekir.2022.01.1066","article-title":"Integrating CKD into US primary care: bridging the knowledge and implementation gaps","volume":"7","author":"Vassalotti","year":"2022","journal-title":"Kidney Int. Rep."},{"issue":"3","key":"10.1016\/j.pcd.2024.09.001_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2337\/cd23-0074","article-title":"Best-practice perspectives on improving early detection and management of chronic kidney disease associated with type 2 diabetes in primary care","volume":"42","author":"Goldman","year":"2024","journal-title":"Clin. Diabetes"},{"issue":"5","key":"10.1016\/j.pcd.2024.09.001_bib48","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11606-019-05353-4","article-title":"Translating CKD research into primary care practice: a group-randomized Study","volume":"35","author":"Litvin","year":"2020","journal-title":"J. Gen. Intern Med."},{"issue":"7","key":"10.1016\/j.pcd.2024.09.001_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jamainternmed.2024.0708","article-title":"Electronic health record population health management for chronic kidney disease care: a cluster randomized clinical trial","volume":"184","author":"Jhamb","year":"2024","journal-title":"JAMA Intern Med."},{"issue":"7","key":"10.1016\/j.pcd.2024.09.001_bib50","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s11606-019-04975-y","article-title":"Primary care physicians' perceived barriers to nephrology referral and co-management of patients with CKD: a qualitative study","volume":"34","author":"Greer","year":"2019","journal-title":"J. Gen. Intern Med"},{"issue":"4","key":"10.1016\/j.pcd.2024.09.001_bib51","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2215\/CJN.06610810","article-title":"Multidisciplinary team care may slow the rate of decline in renal function","volume":"6","author":"Bayliss","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.pcd.2024.09.001_bib52","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ecl.2013.06.001","article-title":"Diabetic neuropathy","volume":"42","author":"Vinik","year":"2013","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.pcd.2024.09.001_bib53","doi-asserted-by":"crossref","unstructured":"2022, Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes, 2022. 40(1): p. 10-38.","DOI":"10.2337\/cd22-as01"},{"issue":"15","key":"10.1016\/j.pcd.2024.09.001_bib54","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N. Engl. J. Med"},{"issue":"34","key":"10.1016\/j.pcd.2024.09.001_bib55","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.pcd.2024.09.001_bib56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.34067\/KID.0003122021","article-title":"Modifiable lifestyle behaviors and CKD progression: a narrative review","volume":"3","author":"Schrauben","year":"2022","journal-title":"Kidney 360"},{"issue":"2","key":"10.1016\/j.pcd.2024.09.001_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/ndt\/gfac331","article-title":"The foundation and the four pillars of treatment for cardiorenal protection in people with chronic kidney disease and type 2 diabetes","volume":"38","author":"Agarwal","year":"2022","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.pcd.2024.09.001_bib58","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.pcd.2024.09.001_bib59","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jand.2018.05.023","article-title":"Medical nutrition therapy for patients with non\u2013dialysis-dependent chronic kidney disease: barriers and solutions","volume":"118","author":"Kramer","year":"2018","journal-title":"J. Acad. Nutr. Diet."},{"issue":"3","key":"10.1016\/j.pcd.2024.09.001_bib60","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.pcd.2024.09.001_bib61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.jrn.2020.05.002","article-title":"The international society of renal nutrition and metabolism commentary on the national kidney foundation and academy of nutrition and dietetics KDOQI clinical practice guideline for nutrition in chronic kidney disease","volume":"31","author":"Kistler","year":"2021","journal-title":"J. Ren. Nutr."},{"issue":"4","key":"10.1016\/j.pcd.2024.09.001_bib62","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","author":"de Boer","year":"2020","journal-title":"Kidney Int."},{"issue":"21","key":"10.1016\/j.pcd.2024.09.001_bib63","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/eurheartj\/ehu051","article-title":"Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial","volume":"35","author":"Jennings","year":"2014","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.pcd.2024.09.001_bib64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40265-020-01290-3","article-title":"ACE inhibitor benefit to kidney and cardiovascular outcomes for patients with non-dialysis chronic kidney disease stages 3-5: a network meta-analysis of randomised clinical trials","volume":"80","author":"Zhang","year":"2020","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.pcd.2024.09.001_bib65","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.pcd.2024.09.001_bib66","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.2337\/dc15-0642","article-title":"Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport: from bench to bedside","volume":"38","author":"Mudaliar","year":"2015","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.pcd.2024.09.001_bib67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4239\/wjd.v11.i7.269","article-title":"Sodium-glucose cotransporter 2 inhibitors' mechanisms of action in heart failure","volume":"11","author":"Grubi\u0107 Rotkvi\u0107","year":"2020","journal-title":"World J. Diabetes"},{"issue":"21","key":"10.1016\/j.pcd.2024.09.001_bib68","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2024.09.001_bib69","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2024.09.001_bib70","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.pcd.2024.09.001_bib71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.pcd.2024.09.001_bib72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur. Heart J."},{"issue":"31","key":"10.1016\/j.pcd.2024.09.001_bib73","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1093\/eurheartj\/ehac299","article-title":"Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease","volume":"43","author":"Pandey","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pcd.2024.09.001_bib74","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.pcd.2024.09.001_bib75","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.pcd.2024.09.001_bib76","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur. Heart J."},{"issue":"Supplement_1","key":"10.1016\/j.pcd.2024.09.001_bib77","first-page":"S219","article-title":"11. Chronic kidney disease and risk management: standards of care in diabetes\u20142024","volume":"47","author":"Committee","year":"2023","journal-title":"Diabetes Care"},{"issue":"37","key":"10.1016\/j.pcd.2024.09.001_bib78","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.pcd.2024.09.001_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.360","article-title":"Potassium management with finerenone: practical aspects","volume":"5","author":"Wanner","year":"2022","journal-title":"Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.pcd.2024.09.001_bib80","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","author":"Agarwal","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pcd.2024.09.001_bib81","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfae041","article-title":"A European renal association (ERA) synopsis for nephrology practice of the 2023 European society of hypertension (ESH) guidelines for the management of arterial hypertension","author":"Sarafidis","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.pcd.2024.09.001_bib82","article-title":"Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"1","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcd.2024.09.001_bib83","unstructured":"Bayer AG. Kerendia (finerenone) Prescribing Information. 2021. \u3008https:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Kerendia_PI.pdf\u3009."},{"key":"10.1016\/j.pcd.2024.09.001_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad139","article-title":"Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European renal best practice (ERBP) board of the European renal association (ERA)","author":"Sarafidis","year":"2023","journal-title":"Clin. Kidney J."},{"issue":"3","key":"10.1016\/j.pcd.2024.09.001_bib85","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.ajkd.2021.09.020","article-title":"Too many for too few: finding appropriate nephrology referrals for patients with CKD that optimize outcomes","volume":"79","author":"Chu","year":"2022","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.pcd.2024.09.001_bib86","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1186\/s12889-021-10959-7","article-title":"A qualitative study documenting unmet needs in the management of diabetic kidney disease (DKD) in the primary care setting","volume":"21","author":"Datar","year":"2021","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.pcd.2024.09.001_bib87","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.pcd.2024.09.001_bib88","doi-asserted-by":"crossref","unstructured":"11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care, 2022. 45(Suppl 1): p. S175-S184.","DOI":"10.2337\/dc22-S011"},{"key":"10.1016\/j.pcd.2024.09.001_bib90","unstructured":"Gesine Weckmann, J.-F.C., Sylvia Stracke, DEGAM S3-Leitlinie: Versorgung von Patienten mit chronischer nicht- dialysepflichtiger Nierenerkrankung in der Hausarzt-praxis. Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin (DEGAM), Berlin, 2019. DEGAM-Leitlinie Nr. 22."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991824001876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991824001876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:39:22Z","timestamp":1732149562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991824001876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1751991824001876"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2024.09.001","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of finerenone in the management of CKD in T2D \u2013Practical considerations for primary care","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}